Metagenomi Stock

metagenomi.coHealthcare / BioTech & PharmaFounded: 2018

Metagenomi is a research and development biotech company focused on gene editing and gene therapy to treat human diseases and other ailments. The private company partners with scientists and field experts to develop gene editing systems that are derived from elements found in nature.

Register To Buy and Sell Shares

For more details on financing and valuation for Metagenomi, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Metagenomi’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Metagenomi.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Brian C. Thomas, PhD
Founder and Chief Executive Officer
Alan Cohen, MD
Chief Medical Officer and SVP of Monogenic Diseases
Jian Irish, PhD.
President and Chief Operating Officer
Simon Harnest, MSc
Chief Investment Officer and SVP of Strategy

Board Members

Jürgen Eckhardt, MD, MBA
Sebastian Bernales, PhD
Hum­boldt Fund
Willard H. Dere, MD
University of Utah
Risa Stack, PhD
The Production Board
Santhosh Palani, PhD, CFA
PFM Data Sciences

Frequently Asked Questions About Metagenomi’s Stock

Can you buy Metagenomi’s stock?
Metagenomi is not publicly traded on NYSE or NASDAQ in the U.S. To buy Metagenomi’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Metagenomi’s stock?
Yes, you can sell stock of a private company like Metagenomi. Forge can help you sell your Metagenomi stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Metagenomi’s stock price?
Metagenomi is a privately held company and therefore does not have a public stock price. However, you may access Metagenomi’s private market stock price with Forge Data.
What is Metagenomi’s stock ticker symbol?
Metagenomi does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Metagenomi Closes Oversubscribed Series B Financing Totaling $275M to Advance Lead Therapeutic Programs into Clinical Development and Grow Genetic Medicines Pipeline
$100M Series B extension financing co-led by Novo Holdings A/S, Catalio Capital Management and SymBiosis, with participation from new and existing investors, including Leaps by Bayer and Moderna, as well as the initial Series B leads PFM Health Sciences, Farallon Capital Management, and a leading global investment firm.
Updated on: Apr 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.